Institutions Holding Call Options on Cytokinetics Inc (CYTK)
This table provides information about the call option holders of Cytokinetics Inc (CYTK). We have compiled data on the institutions that hold call options on the stock, with a total of 4.6 Million call options outstanding, which have been reported (via 13F filing form) to have a value of $215 Million at the end of the reported quarter. These call option holders have the right, but not the obligation, to buy AAPL shares at a specified price within a certain time frame.
| Holding | Report Date | calls Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Adar1 Capital Management, LLC
Austin, TX |
Nov 14, 2024 Q3 2024 |
15,100
calls
|
$737,937
0.13% of portfolio
|
Q3 2024
Added 15000.0%
|
|
|
Squarepoint Ops LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
13,900
calls
|
$679,293
0.0% of portfolio
|
N/A
|
|
|
Barclays PLC
London, X0 |
Nov 19, 2024 Q3 2024 |
10,000
calls
|
$488,700
0.0% of portfolio
|
N/A
|
|
|
Cutler Group LP
|
Apr 19, 2024 Q1 2024 |
8,600
calls
|
$420,282
0.04% of portfolio
|
N/A
|
|
|
Parallax Volatility Advisers, L.P.
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
7,300
calls
|
$356,751
0.0% of portfolio
|
N/A
|
|
|
Balyasny Asset Management LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
4,700
calls
|
$229,689
0.0% of portfolio
|
Q3 2024
Reduced 97.66%
|
|
|
Ubs Group Ag
|
Nov 14, 2024 Q3 2024 |
600
calls
|
$29,322
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Fny Investment Advisers, LLC
|
Oct 18, 2024 Q3 2024 |
8
calls
|
$390
0.0% of portfolio
|
Q3 2024
Reduced 27.27%
|